100%
Questions marked with an
*
are required
Exit Survey
59th ASH Annual Meeting Friday Scientific Workshop Review Form
WORKSHOP ON INTEGRATIVE CLINICAL & MOLECULAR EPIDEMIOLOGY OF HEMATOLOGIC MALIGNANCIES
*
Q1. The workshop co-chairs, session moderators and speakers orally disclosed conflicts of interest (COI), or the absence of COI, prior to the presentation.
Yes
No
Not Sure
Other
*
Q2. Have you attended ASH Friday Scientific Workshops in the past?
No, this is my first time attending
Yes, I have attended the Friday Scientific Workshop on Hematology and Aging in the past
Yes, I have attended the Friday Scientific Workshop on Myeloid Development in the past
Yes, I have attended the Friday Scientific Workshop on Inherited Hematopoietic Malignancies in the past
Yes, I have attended the Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malinancies in the past
Yes, I have attended the Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies in the past
Q3. The presentations reflected the state of the art of the scientific field for each session.
Yes
No
Not Sure
*
Session #1 - New Findings From Population Studies of B-Cell Lymphoma and Leukemia
*
Session #2 - Next Steps for B-cell Neoplasms Epidemiology: Towards Translation
*
Session #3 - Epidemiology of Myeloid Malignancy: Precursor States and Risk Factor Update
*
Session #4 - Next Steps for Myeloid Neoplasm Clinical & Molecular Epidemiology: Towards Translation
*
Session #5 - Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology
*
Session #6 - T-and NK-cell Lymphoma/Leukemia: Challenges and Opportunities for Epidemiologic Research
*
Session #7 - How to Build an Epidemiological Research Community in T-cell Lymphoma/Leukemia
Comments/Suggestions:
Q4. Session moderators provided appropriate background, context and relevance of the scientific top during the session.
Yes
No
Not Sure
*
James Cerhan
*
Wendy Cozen
*
Linda Morton
*
James Foran
*
Ola Landgren
*
Sophia Wang
*
Amanda Termuhlen
Comments/Suggestions:
Q5. Appropriate speakers were selected for each topic.
Yes
No
Not Sure
*
Jeffrey Switchenko
*
Susan Slager
*
Marta Epeldegui
*
Wendy Cozen
*
Maria Oliveira
*
Smita Bhatia
*
Nancy Gillis
*
Koichi Takahashi
*
Sudipto Mukherjee
*
Lene Sofie Granfeldt Oestgaard
Yes
No
Not Sure
*
Catherine Marinac
*
Sigurður Yngvi Kristinsson
*
Niels Weinhold
*
Elizabeth Brown
*
Mark Fiala
*
Kenneth Carson
*
Amanda Termuhlen
*
Sophia Wang
*
Fredrik Ellin
Comments/Suggestions:
*
Q6. Scientifically controversial areas in the field were addressed.
Yes
No
Not Sure
Other
*
Q7. There was adequate time for questions and discussion.
Yes
No
Not Sure
Other
*
Q8. This workshop’s format is effective and uniquely different from other sessions at the ASH annual meeting.
Yes
No
Not Sure
Other
*
Q9. This workshop had topic overlap with another workshop I attended.
Yes
No
I did not attend another ASH workshop this year
If yes, which one and was this a problem? Explain:
*
Q10. After participating in this workshop, I have an increased awareness of (check all that apply):
New area(s) of investigation (basic, clinical and translational)
Therapeutic options
Multi-investigator collaboration(s)
Professional development
Other
*
Q11. If this workshop is offered again next year, I would like to attend.
Yes
No
Please explain
Q12. Please provide us with suggestions for future workshops:
Q13. Provide us with any additional comments/feedback about the workshop below:
Q14. Please provide your name and email address.
Name
:
Affiliation
:
Email Address
:
Loading...
close
Loading...
Close
qprun4.questionpro.net
Loading...
